{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:48:28Z","timestamp":1790999308679,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,15]]},"DOI":"10.1093\/hmg\/ddi306","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T00:13:12Z","timestamp":1124755992000},"page":"2727-2736","source":"Crossref","is-referenced-by-count":139,"title":["Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy"],"prefix":"10.1093","volume":"14","author":[{"given":"Hannes","family":"Lohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonarda","family":"Ianzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elayne M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron A.","family":"Ackerley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berge A.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,22]]},"reference":[{"key":"key\n\t\t\t\t20171011130717_DDI306C1","doi-asserted-by":"crossref","unstructured":"Lafora, G.R. and Gluck, B. ( 1911 ) Beitrag zur histopathologie der myoklonischen epilepsie. Z. Ges. Neurol. Psychiatry , 6 , 1 \u201314.","DOI":"10.1007\/BF02863929"},{"key":"key\n\t\t\t\t20171011130717_DDI306C2","unstructured":"Chan, E.M., Andrade, D.M., Franceschetti, S. and Minassian, B. ( 2005 ) Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B. Adv. Neurol. , 95 , 47 \u201357."},{"key":"key\n\t\t\t\t20171011130717_DDI306C3","unstructured":"Collins, G.H., Cowden, R.R. and Nevis, A.H. ( 1968 ) Myoclonus epilepsy with Lafora bodies. An ultrastructural and cytochemical study. Arch. Pathol. , 86 , 239 \u2013254."},{"key":"key\n\t\t\t\t20171011130717_DDI306C4","doi-asserted-by":"crossref","unstructured":"Toga, M., Dubois, D. and Hassoun, J. ( 1968 ) Ultrastructure of Lafora bodies. Acta Neuropathol. (Berl.) , 10 , 132 \u2013142.","DOI":"10.1007\/BF00691307"},{"key":"key\n\t\t\t\t20171011130717_DDI306C5","doi-asserted-by":"crossref","unstructured":"Ganesh, S., Delgado-Escueta, A.V., Sakamoto, T., Avila, M.R., Machado-Salas, J., Hoshii, Y., Akagi, T., Gomi, H., Suzuki, T., Amano, K., Agarwala, K.L., Hasegawa, Y., Bai, D.S., Ishihara, T., Hashikawa, T., Itohara, S., Cornford, E.M., Niki, H. and Yamakawa, K. ( 2002 ) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet. , 11 , 1251 \u20131262.","DOI":"10.1093\/hmg\/11.11.1251"},{"key":"key\n\t\t\t\t20171011130717_DDI306C6","doi-asserted-by":"crossref","unstructured":"Minassian, B.A., Lee, J.R., Herbrick, J.A., Huizenga, J., Soder, S., Mungall, A.J., Dunham, I., Gardner, R., Fong, C.Y., Carpenter, S., Jardim, L., Satishchandra, P., Andermann, E., Snead, O.C., 3rd, Lopes-Cendes, I., Tsui, L.C., Delgado-Escueta, A.V., Rouleau, G.A. and Scherer, S.W. ( 1998 ) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. , 20 , 171 \u2013174.","DOI":"10.1038\/2470"},{"key":"key\n\t\t\t\t20171011130717_DDI306C7","doi-asserted-by":"crossref","unstructured":"Minassian, B.A., Ianzano, L., Meloche, M., Andermann, E., Rouleau, G.A., Delgado-Escueta, A.V. and Scherer, S.W. ( 2000 ) Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology , 55 , 341 \u2013346.","DOI":"10.1212\/WNL.55.3.341"},{"key":"key\n\t\t\t\t20171011130717_DDI306C8","doi-asserted-by":"crossref","unstructured":"Ganesh, S., Agarwala, K.L., Ueda, K., Akagi, T., Shoda, K., Usui, T., Hashikawa, T., Osada, H., Delgado-Escueta, A.V. and Yamakawa, K. ( 2000 ) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum. Mol. Genet. , 9 , 2251 \u20132261.","DOI":"10.1093\/oxfordjournals.hmg.a018916"},{"key":"key\n\t\t\t\t20171011130717_DDI306C9","doi-asserted-by":"crossref","unstructured":"Minassian, B.A., Andrade, D.M., Ianzano, L., Young, E.J., Chan, E., Ackerley, C.A. and Scherer, S.W. ( 2001 ) Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase. Ann. Neurol. , 49 , 271 \u2013275.","DOI":"10.1002\/1531-8249(20010201)49:2<271::AID-ANA52>3.0.CO;2-D"},{"key":"key\n\t\t\t\t20171011130717_DDI306C10","doi-asserted-by":"crossref","unstructured":"Chan, E.M., Ackerley, C.A., Lohi, H, Ianzano, L., Cortez, M.A., Shannon, P., Scherer, S.W. and Minassian, B.A. ( 2004 ) Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy . Hum. Mol. Genet. , 13 , 1117 \u20131129.","DOI":"10.1093\/hmg\/ddh130"},{"key":"key\n\t\t\t\t20171011130717_DDI306C11","doi-asserted-by":"crossref","unstructured":"Chan, E.M., Young, E.J., Ianzano, L., Munteanu, I., Zhao, X., Christopoulos, C.C., Avanzini, G., Elia, M., Ackerley, C.A., Jovic, N.J., Bohlega, S., Andermann, E., Rouleau, G.A., Delgado-Escueta, A.V., Minassian, B.A. and Scherer, S.W. ( 2003 ) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat. Genet. , 35 , 125 \u2013127.","DOI":"10.1038\/ng1238"},{"key":"key\n\t\t\t\t20171011130717_DDI306C12","doi-asserted-by":"crossref","unstructured":"Chan, E.M., Omer, S., Ahmed, M., Bridges, L.R., Bennett, C., Scherer, S.W. and Minassian, B.A. ( 2004 ) Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology , 63 , 565 \u2013567.","DOI":"10.1212\/01.WNL.0000133215.65836.03"},{"key":"key\n\t\t\t\t20171011130717_DDI306C13","doi-asserted-by":"crossref","unstructured":"Robitaille, Y., Carpenter, S., Karpati, G. and DiMauro, S.D. ( 1980 ) A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. Brain , 103 , 315 \u2013336.","DOI":"10.1093\/brain\/103.2.315"},{"key":"key\n\t\t\t\t20171011130717_DDI306C14","doi-asserted-by":"crossref","unstructured":"Lossos, A., Meiner, Z., Barash, V, Soffer, D., Schlesinger, I., Abramsky, O., Argov, Z., Shpitzen, S. and Meiner, V. ( 1998 ) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann. Neurol. , 44 , 867 \u2013872.","DOI":"10.1002\/ana.410440604"},{"key":"key\n\t\t\t\t20171011130717_DDI306C15","doi-asserted-by":"crossref","unstructured":"Cavanagh, J.B. ( 1999 ) Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Rev. , 29 , 265 \u2013295.","DOI":"10.1016\/S0165-0173(99)00003-X"},{"key":"key\n\t\t\t\t20171011130717_DDI306C16","doi-asserted-by":"crossref","unstructured":"Singhrao, S.K., Neal, J.W. and Newman, G.R. ( 1993 ) Corpora amylacea could be an indicator of neurodegeneration. Neuropathol. Appl. Neurobiol. , 19 , 269 \u2013276.","DOI":"10.1111\/j.1365-2990.1993.tb00437.x"},{"key":"key\n\t\t\t\t20171011130717_DDI306C17","doi-asserted-by":"crossref","unstructured":"Chung, M.H. and Horoupian, D.S. ( 1996 ) Corpora amylacea: a marker for mesial temporal sclerosis. J. Neuropathol. Exp. Neurol. , 55 , 403 \u2013408.","DOI":"10.1097\/00005072-199604000-00002"},{"key":"key\n\t\t\t\t20171011130717_DDI306C18","doi-asserted-by":"crossref","unstructured":"Nishio, S., Morioka, T., Kawamura, T., Fukui, K., Nonaka, H. and Matsushima, M. ( 2001 ) Corpora amylacea replace the hippocampal pyramidal cell layer in a patient with temporal lobe epilepsy. Epilepsia , 42 , 960 \u2013962.","DOI":"10.1046\/j.1528-1157.2001.01601.x"},{"key":"key\n\t\t\t\t20171011130717_DDI306C19","doi-asserted-by":"crossref","unstructured":"Roach, P.J. ( 2002 ) Glycogen and its metabolism. Curr. Mol. Med. , 2 , 101 \u2013120.","DOI":"10.2174\/1566524024605761"},{"key":"key\n\t\t\t\t20171011130717_DDI306C20","doi-asserted-by":"crossref","unstructured":"Hays, A.P., Hallett, M., Delfs, J., Morris, J., Sotrel, A., Shevchuk, M.M. and DiMauro, S. ( 1981 ) Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology , 31 , 1077 \u20131086.","DOI":"10.1212\/WNL.31.9.1077"},{"key":"key\n\t\t\t\t20171011130717_DDI306C21","doi-asserted-by":"crossref","unstructured":"Raben, N., Danon, M., Lu, N., Lee, E., Shliselfeld, L., Skurat, A.V., Roach, P.J., Lawrence, J.C., Jr., Musumeci, O., Shanske, S., DiMauro, S. and Plotz, P. ( 2001 ) Surprises of genetic engineering: a possible model of polyglucosan body disease. Neurology , 56 , 1739 \u20131745.","DOI":"10.1212\/WNL.56.12.1739"},{"key":"key\n\t\t\t\t20171011130717_DDI306C22","doi-asserted-by":"crossref","unstructured":"Fernandez-Sanchez, M.E., Criado-Garcia, O., Heath, K.E., Garcia-Fojeda, B., Medrano-Fernandez, I., Gomez-Garre, P., Sanz, P., Serratosa, J.M. and Rodriguez De Cordoba, S. ( 2003 ) Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum. Mol. Genet. , 12 , 3161 \u20133171.","DOI":"10.1093\/hmg\/ddg340"},{"key":"key\n\t\t\t\t20171011130717_DDI306C23","doi-asserted-by":"crossref","unstructured":"Jope, R.S. and Johnson, G.V. ( 2004 ) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. , 29 , 95 \u2013102.","DOI":"10.1016\/j.tibs.2003.12.004"},{"key":"key\n\t\t\t\t20171011130717_DDI306C24","doi-asserted-by":"crossref","unstructured":"Harwood, A.J. ( 2001 ) Regulation of GSK-3: a cellular multiprocessor. Cell , 105 , 821 \u2013824.","DOI":"10.1016\/S0092-8674(01)00412-3"},{"key":"key\n\t\t\t\t20171011130717_DDI306C25","doi-asserted-by":"crossref","unstructured":"Dajani, R., Fraser, E., Roe, S.M., Young, N., Good, V., Dale, T.C. and Pearl, L.H. ( 2001 ) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell , 105 , 721 \u2013732.","DOI":"10.1016\/S0092-8674(01)00374-9"},{"key":"key\n\t\t\t\t20171011130717_DDI306C26","doi-asserted-by":"crossref","unstructured":"Eldar-Finkelman, H. ( 2002 ) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. , 8 , 126 \u2013132.","DOI":"10.1016\/S1471-4914(01)02266-3"},{"key":"key\n\t\t\t\t20171011130717_DDI306C27","doi-asserted-by":"crossref","unstructured":"Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. and Hemmings, B.A. ( 1995 ) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature , 378 , 785 \u2013789.","DOI":"10.1038\/378785a0"},{"key":"key\n\t\t\t\t20171011130717_DDI306C28","doi-asserted-by":"crossref","unstructured":"Ianzano, L., Young, E.J., Zhao, X.C., Chan, E.M., Rodriguez, M.T., Torrado, M.V., Scherer, S.W. and Minassian, B.A. ( 2004 ) Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy. Hum. Mutat. , 23 , 170 \u2013176.","DOI":"10.1002\/humu.10306"},{"key":"key\n\t\t\t\t20171011130717_DDI306C29","doi-asserted-by":"crossref","unstructured":"Ianzano, L., Zhao, X.C., Minassian, B.A. and Scherer, S.W. ( 2003 ) Identification of a novel protein interacting with laforin, the EPM2A progressive myoclonus epilepsy gene product. Genomics , 81 , 579 \u2013587.","DOI":"10.1016\/S0888-7543(03)00094-6"},{"key":"key\n\t\t\t\t20171011130717_DDI306C30","doi-asserted-by":"crossref","unstructured":"Joazeiro, C.A. and Weissman, A.M. ( 2002 ) RING finger proteins: mediators of ubiquitin ligase activity. Cell , 102 , 549 \u2013552.","DOI":"10.1016\/S0092-8674(00)00077-5"},{"key":"key\n\t\t\t\t20171011130717_DDI306C31","doi-asserted-by":"crossref","unstructured":"Jackson, P.K., Eldridge, A.G., Freed, E., Furstenthal, L., Hsu, J.Y., Kaiser, B.K. and Reimann, J.D. ( 2000 ) The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. , 10 , 429 \u2013439.","DOI":"10.1016\/S0962-8924(00)01834-1"},{"key":"key\n\t\t\t\t20171011130717_DDI306C32","doi-asserted-by":"crossref","unstructured":"Sun, L. and Chen, Z.J. ( 2004 ) The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. , 16 , 119 \u2013126.","DOI":"10.1016\/j.ceb.2004.02.005"},{"key":"key\n\t\t\t\t20171011130717_DDI306C33","doi-asserted-by":"crossref","unstructured":"Wang, J., Stuckey, J.A., Wishart, M.J. and Dixon, J.E. ( 2002 ) A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem. , 277 , 2377 \u20132380.","DOI":"10.1074\/jbc.C100686200"},{"key":"key\n\t\t\t\t20171011130717_DDI306C34","doi-asserted-by":"crossref","unstructured":"Coutinho, P.M., Deleury, E., Davies, G.J. and Henrissat, B. ( 2003 ) An evolving hierarchical family classification for glycosyltransferases. J. Mol. Biol. , 328 , 307 \u2013317.","DOI":"10.1016\/S0022-2836(03)00307-3"},{"key":"key\n\t\t\t\t20171011130717_DDI306C35","doi-asserted-by":"crossref","unstructured":"Ganesh, S., Tsurutani, N., Suzuki, T., Hoshii, Y., Ishihara, T., Delgado-Escueta, A.V. and Yamakawa, K. ( 2004 ) The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. , 313 , 1101 \u20131109.","DOI":"10.1016\/j.bbrc.2003.12.043"},{"key":"key\n\t\t\t\t20171011130717_DDI306C36","doi-asserted-by":"crossref","unstructured":"Wang, W. and Roach, P.J. ( 2004 ) Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Biochem. Biophys. Res. Commun. , 325 , 726 \u2013730.","DOI":"10.1016\/j.bbrc.2004.10.083"},{"key":"key\n\t\t\t\t20171011130717_DDI306C37","doi-asserted-by":"crossref","unstructured":"Lochhead, P.A., Coghlan, M., Rice, S.Q. and Sutherland, C. ( 2001 ) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes , 50 , 937 \u2013946.","DOI":"10.2337\/diabetes.50.5.937"},{"key":"key\n\t\t\t\t20171011130717_DDI306C38","doi-asserted-by":"crossref","unstructured":"Finlay, D., Patel, S., Dickson, L.M., Shpiro, N., Marquez, R., Rhodes, C.J. and Sutherland, C. ( 2004 ) Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element. BMC Mol. Biol. , 5 , 15.","DOI":"10.1186\/1471-2199-5-15"},{"key":"key\n\t\t\t\t20171011130717_DDI306C39","doi-asserted-by":"crossref","unstructured":"Broadwell, R.D. and Cataldo, A.M. ( 1984 ) The neuronal endoplasmic reticulum: its cytochemistry and contribution to the endomembrane system. II. Axons and terminals. J. Comp. Neurol. , 230 , 231 \u2013248.","DOI":"10.1002\/cne.902300208"},{"key":"key\n\t\t\t\t20171011130717_DDI306C40","doi-asserted-by":"crossref","unstructured":"Broman, K.W., Murray, J.C., Sheffield, V.C., White, R.L. and Weber, J.L. ( 1998 ) Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am. J. Hum. Genet. , 63 , 861 \u2013869.","DOI":"10.1086\/302011"},{"key":"key\n\t\t\t\t20171011130717_DDI306C41","unstructured":"Machado-Salas, J., Bai, D., Rosa-Avila, M., Ganesh, S., Yamakawa, K., Suzuki, T., Amano, K., Cornford, E.M. and Delgado-Escueta, A.V. ( 2004 ) Is Lafora disease a disorder of protein degradation and clearance? Neurology , 62 , A253\u2013A254."},{"key":"key\n\t\t\t\t20171011130717_DDI306C42","doi-asserted-by":"crossref","unstructured":"Avila, J., Lucas, J.J., Perez, M. and Hernandez, F. ( 2004 ) Role of tau protein in both physiological and pathological conditions. Physiol. Rev. , 84 , 361 \u2013384.","DOI":"10.1152\/physrev.00024.2003"},{"key":"key\n\t\t\t\t20171011130717_DDI306C43","doi-asserted-by":"crossref","unstructured":"Morfini, G., Szebenyi, G., Brown, H., Pant, H.C., Pigino, G., DeBoer, S., Beffert, U. and Brady, S.T. ( 2004 ) A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. , 23 , 2235 \u20132245.","DOI":"10.1038\/sj.emboj.7600237"},{"key":"key\n\t\t\t\t20171011130717_DDI306C44","doi-asserted-by":"crossref","unstructured":"Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S. and Goldstein, L.S. ( 2005 ) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science , 307 , 1282 \u20131288.","DOI":"10.1126\/science.1105681"},{"key":"key\n\t\t\t\t20171011130717_DDI306C45","doi-asserted-by":"crossref","unstructured":"Sergeant, N., Delacourte, A. and Buee, L. ( 2005 ) Tau protein as a differential biomarker of tauopathies. Biochim. Biophys. Acta , 1739 , 179 \u2013197.","DOI":"10.1016\/j.bbadis.2004.06.020"},{"key":"key\n\t\t\t\t20171011130717_DDI306C46","doi-asserted-by":"crossref","unstructured":"Nordli, D. ( 2002 ) The ketogenic diet: uses and abuses. Neurology , 58 , S21 \u2013S24.","DOI":"10.1212\/WNL.58.12_suppl_7.S21"},{"key":"key\n\t\t\t\t20171011130717_DDI306C47","doi-asserted-by":"crossref","unstructured":"Gentry, M.S., Worby, C.A. and Dixon, J.E. ( 2005 ) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl Acad. Sci. USA , 102 , 8501 \u20138506.","DOI":"10.1073\/pnas.0503285102"},{"key":"key\n\t\t\t\t20171011130717_DDI306C48","doi-asserted-by":"crossref","unstructured":"Lohi, H., Young, E.J., Fitzmaurice, S.N., Rusbridge, C., Chan, E.M., Vervoort, M., Turnbull, J., Zhao, X.C., Ianzano, L., Paterson, A.D., Sutter, N.B., Ostrander, E.A., Andre, C., Shelton, G.D., Ackerley, C.A., Scherer, S.W. and Minassian, B.A. ( 2005 ) Expanded repeat in canine epilepsy. Science , 307 , 81 .","DOI":"10.1126\/science.1102832"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/18\/2727\/6949329\/ddi306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T04:45:42Z","timestamp":1586407542000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/18\/2727\/2355824\/Novel-glycogen-synthase-kinase-3-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,22]]},"references-count":48,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2005,8,22]]},"published-print":{"date-parts":[[2005,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi306","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9,15]]},"published":{"date-parts":[[2005,8,22]]}}}